Regenxbio Inc share price logo

Regenxbio Inc

NASDAQ: RGNX

Small Cap

$10.08

-0.14

(-1.37%)

Live

as on

Regenxbio Inc Stock Performance

as on May 8, 2026 at 1:11 am IST

  • Day's Low

    Day's High

    $9.90
    $10.35
    downward going graph

    1.79%

    Downside

    2.68%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.89
    $16.19
    downward going graph

    31.65%

    Downside

    60.62%

    Upside

    downward going graph

Regenxbio Inc share price movements today

Previous Close
$10.22
Open
$10.11
Volume
200.8K
Day's Low - High
$9.90 - $10.35
52 Week Low - High
$6.89 - $16.19

Regenxbio Inc Historical Returns

1 Month Return
+ 16.14 %
3 Month Return
-1.06 %
1 Year Return
+ 41.16 %
3 Year Return
-45.87 %
5 Year Return
-71.82 %

Regenxbio Inc Stock Fundamentals & Key Indicators

Check Regenxbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$475.9M

EPS (TTM)

-1.9988

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.26

EBITDA

-145.6M

Revenue (TTM)

170.4M

Profit Margin

-113.75%

Return On Equity TTM

-107.00%

Regenxbio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Regenxbio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$475.9M-71.82%NA-113.75%
BUY$40.5B130.77%76.3212.55%
BUY$108.5B98.9%25.3835.51%
NA$32.5BNA70.895.37%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Regenxbio Inc Stock including INR - Dollar returns

The Regenxbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Regenxbio Inc investment value today

Current value as on today

₹1,54,869

Returns

₹54,869

(+54.87%)

Returns from Regenxbio Inc Stock

₹39,227 (+39.23%)

Dollar Impact

₹15,642 (+15.64%)

Analyst Recommendation on Regenxbio Inc Stock

Based on 18 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 18 analysts, 88.89% of analysts recommend a 'BUY' rating for Regenxbio Inc. Average target price of $27.82

Regenxbio Inc Share Price Target

Get share price movements and forecasts by analysts on Regenxbio Inc.

What analysts predicted

63.77%UPSIDE

Target Price

$27.82

Current Price

$10.08

Analyzed by

18 Analysts

Target

$27.82

Regenxbio Inc target price $27.82, a slight upside of 63.77% compared to current price of $10.08. According to 18 analysts rating.

Indian Investors' Interest in Regenxbio Inc Stock

Search interest for Regenxbio Inc Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Regenxbio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
28
22
15
22
24
21
89
21
29
30
Gross Profit
16
6
7
7
11
14
85
12
-32
24
Operating Income
-64
-63
-61
-56
-62
-51
12
-63
-52
-57
EBITDA
-55
-57
-57
-48
-54
-37
18
-55
-44
-63
Interest Expense
1
1
1
0
0
9
8
10
13
12
Depreciation
4
4
4
4
3
4
3
3
3
3
Income Before Tax
-61
-63
-63
-52
-59
-51
6
-70
-61
-67
Income Tax Expense
-2
0
0
-
-
-
-
-
-
-
Net Income
-61
-62
-63
-52
-59
-51
6
-70
-61
-67
Net Profit Margin
-213.97%
-283.12%
-405.39%
-237.67%
-246.30%
-241.28%
6.83%
-331.81%
-208.32%
-221.34%

Regenxbio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
10
218
35
154
470
112
90
83
170
Gross Profit
3
8
208
26
118
418
58
53
49
150
Operating Income
-65
-75
88
-148
-119
159
-262
-268
-233
-161
EBITDA
-64
-73
92
-90
-96
169
-244
-239
-198
-145
Interest Expense
-
-
-
107
0
26
23
6
12
45
Depreciation
-
2
3
7
8
9
12
17
16
15
Income Before Tax
-63
-73
104
-97
-106
141
-280
-263
-227
-193
Income Tax Expense
0
0
4
-2
5
13
0
0
-
-
Net Income
-62
-73
99
-94
-111
127
-280
-263
-227
-193
Net Profit Margin
-1372.13%
-704.02%
45.74%
-268.88%
-71.98%
27.18%
-248.68%
-291.99%
-272.54%
-113.75%

Regenxbio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-62
-63
-52
-59
-51
6
-70
-61
-67
Operating Cash Flow
-40
-55
-45
-40
-31
33
-49
-55
-52
Investing Cash Flow
33
13
0
50
40
44
-140
42
37
Financing Cash Flow
-11
120
-9
-10
-7
-5
139
-7
-9
Change in Cash
-18
78
-55
-1
0
72
-50
-20
-24

Regenxbio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-73
99
-94
-111
127
-280
-263
-227
-193
Operating Cash Flow
-57
104
-107
-54
218
-207
-218
-173
-123
Investing Cash Flow
-4
-279
93
122
-406
-11
190
103
-15
Financing Cash Flow
84
204
8
200
195
-28
-34
92
116
Change in Cash
21
29
-5
268
7
-248
-62
23
-23

Global Institutional Holdings in Regenxbio Inc

Funds
Holdings
Morgan Stanley - Brokerage Accounts
3.35%
JPMorgan Chase & Co
6.88%
The Goldman Sachs Group Inc
3.59%
State Street Corp
4.43%
Geode Capital Management, LLC
2.22%

Regenxbio Inc News & Key Events

  • img

    Today's Timeline - 11 January

    Mon, 01:30 AM

    -

    REGENXBIO announces positive long-term data for Duchenne therapy and outlines key 2026 catalysts, including BLA submission and pivotal trial updates.

Insights on Regenxbio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 21.35M → 30.33M (in $), with an average increase of 15.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RGNX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RGNX stock has moved up by 13.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 71.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -61.94M → -67.14M (in $), with an average decrease of 8.4% per quarter

About Regenxbio Inc

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202 for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 and with Nippon Shinyaku Co., Ltd. to develop RGX-121 and RGX-111 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
OrganisationRegenxbio Inc
Headquarters9804 Medical Center Drive, Rockville, MD, United States, 20850
IndustryBiotechnology
CEOMr. Curran M. Simpson M.S.
E-voting on sharesClick here to vote

Key Management of Regenxbio Inc

Name

Title

Mr. Craig Malzahn

Executive VP of Product Development & CTO

Dr. Olivier Danos Ph.D.

Executive VP & Chief Scientific Officer

Dr. Ram Palanki Pharm.D.

Executive VP & Chief Commercial Officer

Mr. Curran M. Simpson M.S.

President, CEO & Director

Mr. Patrick J. Christmas II, J.D.

Executive VP & Chief Strategy and Legal Officer

Dr. Stephen Pakola M.D.

Executive VP & Chief Medical Officer

Mr. Mitchell Chan M.B.A.

Executive VP & CFO

Ms. Shiva G. Fritsch

Chief Communications & People Officer

Ms. Nina Hunter

SVP of Global Regulatory Strategy and Quality

Dr. Jahannaz Dastgir D.O.

Clinical Development Lead

FAQs

What is Regenxbio Inc share price today?

Regenxbio Inc share price today is $10.08 as on . Regenxbio Inc share today touched a day high of $10.35 and a low of $9.9.

What is the 52 week high and 52 week low for Regenxbio Inc share?

Regenxbio Inc share touched a 52 week high of $16.19 on and a 52 week low of $6.89 on . Regenxbio Inc stock price today i.e. is trending at $10.08,which is 37.74% down from its 52 week high and 46.30% up from its 52 week low.

What is Regenxbio Inc's market capitalisation today?

Regenxbio Inc market capitalisation is $0.00T as on .

How to invest in Regenxbio Inc Stock (RGNX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Regenxbio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regenxbio Inc Shares that will get you 0.1488 shares as per Regenxbio Inc share price of $10.08 per share as on May 7, 2026 at 7:41 pm IST.

What is the minimum amount required to buy Regenxbio Inc Stock (RGNX) from India?

Indian investors can start investing in Regenxbio Inc (RGNX) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Regenxbio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Regenxbio Inc share’s latest price of $10.08 as on May 7, 2026 at 7:41 pm IST, you will get 0.9921 shares of Regenxbio Inc. Learn more about fractional shares .

What are the returns that Regenxbio Inc has given to Indian investors in the last 5 years?

Regenxbio Inc stock has given -71.82% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?